Login:
Share:
Email Facebook Twitter

IMM Share Chat - RSS Feed

Immupharma Share Chat (IMM)



Share Price: 57.75Bid: 57.50Ask: 58.00Change: 0.00 (0.00%)No Movement on Immupharma
Spread: 0.50Spread as %: 0.87%Open: 57.75High: 57.75Low: 57.75Yesterday’s Close: 57.75


Share Discussion for Immupharma (IMM)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


LeMoore
Posts: 1,847
Off Topic
Opinion:No Opinion
Price:66.00
leas
2 Oct '13
I tried to warn but as usual was mocked and jeered.
 
leas
Posts: 2,869
Off Topic
Opinion:No Opinion
Price:66.00
LeMoore
2 Oct '13
Feel for those invested long term atm, as the ID hype drew a few in. It will come good though but patience is the key. (as with all bio's) I know you cannot compare companies, but as I mentioned yesterday this is about apples and pears. Selling at the market. IMM has it's stall set up and SCLP are still waiting to harvest them. That is not to say that IMM's fruit will be any sweeter. Give up your 10k shares and buy more IMM. We need a nudge. I have it on good authority that the current Mrs LeMoore agrees.
LeMoore
Posts: 1,847
Off Topic
Opinion:No Opinion
Price:66.00
leas
2 Oct '13
wouldnt go near it until its back in the 20's.

good trade mate, we read the market well.

they laughed at my 20%.. haha, who is laughing now!
leas
Posts: 2,869
Off Topic
Opinion:No Opinion
Price:66.50
LeMoore
2 Oct '13
glad I recycled my SCLP by buying some more IMM shares. I can see SCLP dropping back to near the recent placement price. Investors seem to want instant gratification nowadays, if not then they quickly move on. I can see a good investment opportunity when the sp settles before any significant news.
cthed
Posts: 141
Answer
Opinion:No Opinion
Price:66.50
View Thread (3)
RE: 1bn
2 Oct '13
And I will retire!
leas
Posts: 2,869
Off Topic
Opinion:No Opinion
Price:66.50
View Thread (3)
1bn
2 Oct '13
Lupuzor market alone is worth more. A MC above that with a dividend would be very nice.
leas
Posts: 2,869
Off Topic
Opinion:No Opinion
Price:66.50
View Thread (4)
RE: vegas99
2 Oct '13
hamila, have to agree, it would be better for shareholder value if that occurs. That said, after reading and re reading last weeks RNS then it would suggest their intention is clear. Torreya have been engaged for a reason. Their website makes interesting reading. If we get any further updates on IPP ...106 before any deal then we will be in a fantastic position. Imo this will completely derisk the shares.
PAYDAY
Posts: 361
Off Topic
Opinion:Strong Buy
Price:66.50
hamila01
2 Oct '13
I agree £1bn, be happy to take it!!
hamila01
Posts: 362
Off Topic
Opinion:No Opinion
Price:66.50
View Thread (4)
RE: vegas99
2 Oct '13
So for a bit of fun (and not to be taken as gospel as the price is the price that the IMM board accept) on a grey, damp morning what do we all think would be an appropriate takeover price for IMM currently? And if anyone's especially brave what about 2-3 years down the line?

My guess is £1bn at the present time.
boomorbust
Posts: 4,625
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:66.50
The Silent War
2 Oct '13
Interesting article here by US Congresswoman E Johnson. She states the US currently spends $31.4 billion treating Lupus patients each year and talks about the need for new treatments. She is joining an awareness campaign which seems to be a pressure group within Congress to raise awareness and seek new treatments. All good for Lupuzor

http://northdallasgazette.com/2013/10/01/lupus-the-silent-war/



Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.